# Cancer Immunotherapy

The aim of this website is to inform the public about the original tumor immunotherapy, with which we achieve an 80% cure, suppress metastases and gain resistance to disease recurrence in mouse models of melanoma, sarcoma, pancreatic adenocarcinoma, colorectal cancer, pheochromocytoma, breast tumor and glioblastoma.

We strive to translate our knowledge into clinical practice. This process is very costly and time-consuming, it usually takes 12–14 years. Recently we have seen in the context of covid that everything can be shortened to 6 months. We believe that we will find the support of a strong pharmaceutical company allowing us to introduce our tumor immunotherapy into practice soon. Millions of patients are waiting for it.